bioRxivCancer BiologyPreprint
Somatic copy number mutations contribute to fitness in transplantation models of spontaneous human breast cancer metastasis
Hoa TraniD, Gurdeep SinghiD, Hakwoo Lee, Damian YapiD, Eric LeeiD, William Daniels, Farhia KabeeriD, Ciara H. O’FlanaganiD, Vinci AuiD, Michael Van VlietiD, Daniel LaiiD, Elena ZaikovaiD, Sean BeattyiD, Esther KongiD, Shuyu Fan, Jessica ChaniD, Hoang Quan Dang, Viviana Cerda, Teresa Ruiz de Algara, Andrew J. L. RothiD, Samuel A. J. R. AparicioiD
Abstract
The contribution of somatic gene dosage mutations (CNA) to breast cancer metastasis remains poorly defined. Using 9 transplantable human neoadjuvant-naive triple-negative breast cancer xenografts, we studied the fitness of copy number clones in spontaneous metastasis from orthotopic transplant sites. Metastatic site preference was strongly patient-dependent, and the emergence of metastases exhibited a general trend toward slower growth at the orthotopic site. In our models, single-cell whole-genome sequencing of primary and metastatic sites showed that distant metastases were most often the result of minor prevalence clones at the orthotopic site, suggesting that some metastatic phenotypes may be weakly negatively fit at the primary site. We validated the existence of a fitness hierarchy of copy number clones using a previously established paradigm of remixing and retransplanting clones. Single-cell clone analysis of competitive repopulation and re-emergence of metastases showed that CNAs arising in cancer evolution can mediate metastatic fitness. Moreover, some clones displaying strong metastatic tendency exhibited weaker survival at the primary site, consistent with the notion that metastatic phenotypes could have a fitness cost at the primary site. Finally, we conducted RNA-seq analysis combined with DriverNet analysis to dissect the contribution of CNA-mediated versus genome-independent transcriptional states. CNA mutations appeared to contribute strongly to transcriptional differences between clones. Among clones of high metastatic potential, we observed CNA-mediated and CNA-independent convergence on pathways such as epithelial-mesenchymal transition (EMT), established as mediators of metastatic cell survival at distant sites. Taken together, our data point to a contribution of CNA-mediated cancer evolution to metastatic states and identify distant-site context as a key determinant of CNA-mediated fitness.
- organism: human
- assay: whole-genome sequencing
- research focus: clustering
- research focus: differential expression
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The genomic landscape of metastasis in treatment-naive breast cancer models
C. Ross, K. Szczepanek, … K. Hunter·bioRxiv·Sep 23, 2019
- Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases
- Cancer tissue of origin constrains the growth and metabolism of metastases
S. Sivanand, Y. Gultekin, … M. G. Vander Heiden·bioRxiv·Aug 17, 2022
- Genomic correlates of metastatic competence and progression in human melanoma
Eftychia Chatziioannou, Karan D. Luthria, … Martin Röcken·bioRxiv·Sep 29, 2026
- Novel temporal and spatial patterns of metastatic colonization from rapid-autopsy tumor biopsies
X. Huang, Y. Qiao, … G. T. Marth·bioRxiv·Jun 3, 2021
- LeGO-Teknik reveals that the neurogenesis pathway is a clone-specific hallmark of brain metastasis in breast cancer
Jean Berthelet, Sam Lee, … Delphine Mérino·bioRxiv·Jul 23, 2025